Annual Conference - Beyond One-Size-Fits-All: The Promise and Complexity of Precision Medicine
This year’s Annual Conference will explore how personalised approaches are changing the life sciences landscape, and what this means for clinical research, regulatory & medical affairs, quality, market access and, ultimately, patients.
Precision medicine is reshaping the way therapies are discovered, developed, assessed and brought to patients. From biomarker-driven treatments and radioligand therapies to adaptive clinical development, companion diagnostics, regulatory assessment and market access, innovation increasingly requires collaboration across disciplines.
PRELIMINARY PROGRAM
12:00 – 12:50
Welcome lunch & registration
12:50 – 13:00
Welcome and introduction
Setting the scene: why precision medicine requires cross-functional collaboration.
13:00 – 13:30
How personalized is cancer treatment anno 2026?
Jeroen De Kervel, UZ Leuven
13:30 – 14:00
Radioligand therapies: Targeted treatment at the crossroads of science, care and regulation
Sarah Baatout, SCK CEN
14:00 – 14:30
Beyond the standard dose: Model-Informed precision dosing in clinical practice
Pieter De Cock, UZ Gent
14:30 – 14:45
Healixia Award
14:45 – 15:15
Coffee break
15:15 – 15:45
The Clinical Trial College and the ethics review in clinical drug development in Belgium
Speakers: Lucas Van Bortel and Katelijne Anciaux, CT College
15:45 – 16:15
Joint clinical assessment and ATMPs: Early lessons for evidence, value and access
Francis Arickx, RIZIV-INAMI
16:15 – 16:45
Clinical implementation of comprehensive genomic profiling of tumor tissue and plasma
Geert Martens, AZ Delta
16:45 – 17:15
Benefit–risk assessment in the era of personalised cancer treatments: A regulatory perspective
Olga Kholmanskikh, FAMHP
17:15 – 17:30
Closing reflection: the patient voice
Saartje Hendrickx, CliniClowns
17:30 – 19:00
Networking reception